The Effect of Astragaloside IV on Isoproterenol-Induced Myocardial Infarction in Rats

The Effect of Astragaloside IV on Isoproterenol-Induced Myocardial Infarction in Rats

Background: Astragaloside IV (AST) is a saponin from the roots of Astragalus plants which has been widely used in traditional medicine to treat cardiovascular diseases. However, the effect of AST on myocardial infarction remains unknown. Thus, we aimed to investigate the cardio protective effects of...

Full description

Bibliographic Details
Main Authors:	Fatemeh Fathizad, Nezhla Tamarzadeh, Doa Alsos, Alireza Garjani, Haleh Vaez
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2019-06-01
Series:	Pharmaceutical Sciences
Subjects:	Astragaloside IV Myocardial infarction Isoprotrenol Oxidative stress Isolated heart
Online Access:	https://ps.tbzmed.ac.ir/PDF/PHARM_1744_20180913124301

Similar Items

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
by: Chuang Sun, et al.
Published: (2021-07-01)

Astragaloside IV promotes angiogenesis by targeting SIRT7/VEGFA signaling pathway to improve brain injury after cerebral infarction in rats
by: Zhijie Ou, et al.
Published: (2023-12-01)

Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023-02-01)

Astragaloside IV alleviates lipopolysaccharide‐induced preeclampsia‐like phenotypes via suppressing the inflammatory responses
by: Dilihuma Tuerxun, et al.
Published: (2021-03-01)

Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
by: Lin-Sen Qing, et al.
Published: (2017-07-01)

Astragaloside IV Alleviates Infarction Induced Cardiomyocyte Injury by Improving Mitochondrial Morphology and Function
by: Wen Zhang, et al.
Published: (2022-02-01)

Pharmacological Effects of Astragaloside IV: A Review
by: Yutong Liang, et al.
Published: (2023-08-01)

Research progress of astragaloside IV in the treatment of atopic diseases
by: Shencun Yu, et al.
Published: (2022-12-01)

Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress
by: Chunlan Ji, et al.
Published: (2018-09-01)

Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor
by: Xingkai Liu, et al.
Published: (2022-08-01)

Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
by: Mei-Ling Xia, et al.
Published: (2020-04-01)

Chemical chaperon 4-phenylbutric acid improves cardiac function following isoproterenol-induced myocardial infarction in rats
by: Fatemeh Vatankhah, et al.
Published: (2023-03-01)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
by: Lu-Yun Qin, et al.
Published: (2022-03-01)

Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
by: Zehui Xu, et al.
Published: (2023-12-01)

The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review
by: Tang Ziyang, et al.
Published: (2023-11-01)

Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats
by: Feng Zhao, et al.
Published: (2011-05-01)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
by: Tan YQ, et al.
Published: (2020-09-01)

Astragaloside-IV Alleviates Heat-Induced Inflammation by Inhibiting Endoplasmic Reticulum Stress and Autophagy
by: Zhiwei Dong, et al.
Published: (2017-06-01)

Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis
by: Zhuang Zhuang, et al.
Published: (2019-11-01)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
by: Chunkun Yang, et al.
Published: (2023-05-01)

The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
by: Yiwei Gao, et al.
Published: (2023-07-01)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
by: Tan J, et al.
Published: (2023-07-01)

Astragaloside IV-enhanced anti-hepatocarcinoma immunity of dendritic cells
by: Hongxing Guo, et al.
Published: (2022-05-01)

Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
by: Xu J, et al.
Published: (2021-01-01)

Mechanism of Astragaloside Ⅳ on HepG2 Cells Based on Molecular Dynamics Simulation and Experimental Evaluation
by: ZHOU Zhipeng, et al.
Published: (2022-07-01)

Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII
by: Wanting Qin, et al.
Published: (2024-02-01)

The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
by: Li L, et al.
Published: (2023-03-01)

Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats
by: Ruiqin Huang, et al.
Published: (2016-05-01)

Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
by: Xianhui Kang, et al.
Published: (2021-11-01)

Astragaloside IV Protects Ethanol-Induced Gastric Mucosal Injury by Preventing Mitochondrial Oxidative Stress and the Activation of Mitochondrial Pathway Apoptosis in Rats
by: Shumin Qin, et al.
Published: (2019-08-01)

Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway
by: Xujun You, et al.
Published: (2024-04-01)

Cardioprotective Effects of Rosmarinic Acid on Isoproterenol-Induced Myocardial Infarction in Rats
by: Negisa Seyed Toutounchi, Arash Afrooziyan, Maryam Rameshrad, Aysa Rezabakhsh, Haleh Vaez, Sanaz Hamedeyazdan, Fatemeh Fathiazad, Alireza Garjani
Published: (2017-06-01)

Calcium Sensing Receptor-Related Pathway Contributes to Cardiac Injury and the Mechanism of Astragaloside IV on Cardioprotection
by: Meili Lu, et al.
Published: (2018-10-01)

Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
by: Tiantian Qiu, et al.
Published: (2022-09-01)

Extraction Optimization of Astragaloside IV by Response Surface Methodology and Evaluation of Its Stability during Sterilization and Storage
by: Lin Xu, et al.
Published: (2021-04-01)

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
by: Zhen Xiong Zhao, et al.
Published: (2022-12-01)

Evaluation and Comparison of the Inhibition Effect of Astragaloside IV and Aglycone Cycloastragenol on Various UDP-Glucuronosyltransferase (UGT) Isoforms
by: Ruixue Ran, et al.
Published: (2016-11-01)

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
by: Fei Xu, et al.
Published: (2018-08-01)

Astragaloside IV attenuates neuroinflammation and ameliorates cognitive impairment in Alzheimer’s disease via inhibiting NF-κB signaling pathway
by: Li He, et al.
Published: (2023-02-01)

The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia–reperfusion injury by inhibiting the STING pathway
by: Pan Zhai, et al.
Published: (2024-02-01)